Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches
Process concerns associated with viral-vectors gene delivery currently focus on effective purification, as described by these authors from the Centre for the Advancement of Sustainable Medical Innovation and Sartorius Stedim Biotech. For research into cell-delivered gene therapy platforms to continu...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Published: |
BioProcess International
2017
|
_version_ | 1826274042080919552 |
---|---|
author | Fuerstenau-Sharp, M Pettitt, D Bure, K Smith, J Ware, J Brindley, D |
author_facet | Fuerstenau-Sharp, M Pettitt, D Bure, K Smith, J Ware, J Brindley, D |
author_sort | Fuerstenau-Sharp, M |
collection | OXFORD |
description | Process concerns associated with viral-vectors gene delivery currently focus on effective purification, as described by these authors from the Centre for the Advancement of Sustainable Medical Innovation and Sartorius Stedim Biotech. For research into cell-delivered gene therapy platforms to continue toward development, process characterization and development work are still in need of refinement. |
first_indexed | 2024-03-06T22:37:25Z |
format | Journal article |
id | oxford-uuid:5a606126-0cd9-4538-a2f9-1894c133c24f |
institution | University of Oxford |
last_indexed | 2024-03-06T22:37:25Z |
publishDate | 2017 |
publisher | BioProcess International |
record_format | dspace |
spelling | oxford-uuid:5a606126-0cd9-4538-a2f9-1894c133c24f2022-03-26T17:15:27ZScalable purification of viral vectors for gene therapy: An appraisal of downstream processing approachesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5a606126-0cd9-4538-a2f9-1894c133c24fSymplectic Elements at OxfordBioProcess International2017Fuerstenau-Sharp, MPettitt, DBure, KSmith, JWare, JBrindley, DProcess concerns associated with viral-vectors gene delivery currently focus on effective purification, as described by these authors from the Centre for the Advancement of Sustainable Medical Innovation and Sartorius Stedim Biotech. For research into cell-delivered gene therapy platforms to continue toward development, process characterization and development work are still in need of refinement. |
spellingShingle | Fuerstenau-Sharp, M Pettitt, D Bure, K Smith, J Ware, J Brindley, D Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches |
title | Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches |
title_full | Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches |
title_fullStr | Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches |
title_full_unstemmed | Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches |
title_short | Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches |
title_sort | scalable purification of viral vectors for gene therapy an appraisal of downstream processing approaches |
work_keys_str_mv | AT fuerstenausharpm scalablepurificationofviralvectorsforgenetherapyanappraisalofdownstreamprocessingapproaches AT pettittd scalablepurificationofviralvectorsforgenetherapyanappraisalofdownstreamprocessingapproaches AT burek scalablepurificationofviralvectorsforgenetherapyanappraisalofdownstreamprocessingapproaches AT smithj scalablepurificationofviralvectorsforgenetherapyanappraisalofdownstreamprocessingapproaches AT warej scalablepurificationofviralvectorsforgenetherapyanappraisalofdownstreamprocessingapproaches AT brindleyd scalablepurificationofviralvectorsforgenetherapyanappraisalofdownstreamprocessingapproaches |